[Whitepaper] Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases

The cost of cancer and high-cost chronic noncommunicable diseases (NCDs) are significant and growing, posing an increasingly high burden of disease to health systems, businesses and individuals. Optimal patient outcomes are fundamentally linked to affordability and, despite meaningful efforts within the health system, current traditional funding models will struggle to close the funding gap.

This global landscape study identifies and assesses innovative funding models for cancer and other high-cost chronic NCDs across Africa, Asia, Europe, Latin America and Middle East. The study aims to enable readers to better understand the possibilities that innovative funding models bring to bridge the current and future funding gap, while stressing the key success factors that enable sustainability and success such as stakeholder collaboration.

Sponsored by: